Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3259-3266

  Seneviratne, C J ^a,b   Jin, L J ^a   Samaranayake, Y H ^a   Samaranayake, L P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCYTOSINE; HYDROXIDE; KETOCONAZOLE; NYSTATIN; POLYSTYRENE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL AGING; CELL DENSITY; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELL ADHESION; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYSTYRENES; TIME FACTORS;

EID: 50949124754     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00541-08     Document Type: Article

References (42)

1. Anil, S., A. N. Ellepola, and L. P. Samaranayake. 2002. The impact of polyene, azoic, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection. Mycopathologia 153:179-185.
2. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
3. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:644-656.
4. Baillie, G. S., and L. J. Douglas. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:1900-1905.
5. Baillie, G. S., and L. J. Douglas. 1998. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob. Agents Chemother. 42:2146-2149.
6. Beck-Sagué, C., and W. R. Jarvis. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J. Infect. Dis. 167:1247-1251.
7. Beggs, W. H. 1984. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob. Agents Chemother. 25:316-318.
8. Beggs, W. H. 1991. Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole. Mycoses 34:227-230.
9. Chamilos, G., R. E. Lewis, N. Albert, and D. P. Kontoyiannis. 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother. 51:2257-2259.
10. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
11. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
12. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
13. Cuenca-Estrella, M., C. B. Moore, F. Barchiesi, J. Bille, E. Chryssanthou, D. W. Denning, J. P. Donnelly, F. Dromer, B. Dupont, J. H. Rex, M. D. Richardson, B. Sancak, P. E. Verweij, and J. L. Rodriguez-Tudela. 2003. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin. Microbiol. Infect. 9:467-474.
14. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
15. Harrison, J. J., R. J. Turner, and H. Ceri. 2007. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents. FEMS Microbiol. Lett. 272:172-181.
16. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39: 2128-2131.
17. Jain, N., R. Kohli, E. Cook, P. Gialanella, T. Chang, and B. C. Fries. 2007. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl. Environ. Microbiol. 73:1697-1703.
18. Jin, Y., L. P. Samaranayake, Y. Samaranayake, and H. K. Yip. 2004. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch. Oral Biol. 49:789-798.
19. Jin, Y., H. K. Yip, Y. H. Samaranayake, J. Y. Yau, and L. P. Samaranayake. 2003. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J. Clin. Microbiol. 41:2961-2967.
20. Khot, P. D., P. A. Suci, R. L. Miller, R. D. Nelson, and B. J. Tyler. 2006. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and β-1,6-glucan pathway genes. Antimicrob. Agents Chemother. 50: 3708-3716.
21. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
22. LaFleur, M. D., C. A. Kumamoto, and K. Lewis. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50:3839-3846.
23. Lamfon, H., S. R. Porter, M. McCullough, and J. Pratten. 2004. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J. Antimicrob. Chemother. 53:383-385.
24. Lu, Q., J. A. Jayatilake, L. P. Samaranayake, and L. Jin. 2006. Hyphal invasion of Candida albicans inhibits the expression of human beta-defensins in experimental oral candidiasis. J. Investig. Dermatol. 126:2049-2056.
25. Melo, A. S., A. L. Colombo, and B. A. Arthingron-Skaggs. 2007. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob. Agents Chemother. 51:3081-3088.
26. Mukherjee, P. K., and J. Chandra. 2004. Candida biofilm resistance. Drug Resist. Updates 7:301-309.
27. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts - second edition: Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
28. Perumal, P., S. Mekala, and W. L. Chaffin. 2007. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob. Agents Chemother. 51:2454-2463.
29. Potera, C. 1999. Forging a link between biofilms and disease. Science 283: 1837-1839.
30. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:973-980.
31. Ramage, G., J. P. Martinez, and J. L. Lopez-Ribot. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6:979-986.
32. Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
33. Richardson, M. D. 2005. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56(Suppl. 1):i5-i11.
34. Samaranayake, L. P., and T. W. MacFarlane. 1990. Oral candidosis. Wright-Butterworth, London, United Kingdom.
35. Seneviratne, C. J., L. Jin, and L. P Samaranayake. 7 December 2007, posting date. Biofilm lifestyle of Candida: a mini review. Oral Dis. doi:10.1111/ j.1601-0825.2007.01424.x.
36. Seneviratne, C. J., Y. Wang, L. J. Jin, Y. Abiko, and L. P. Samaranayake. Candida biofilm formation is associated with increased anti-oxidative capacities. Proteomics, in press.
37. Serefko, A., B. Chudzik, and A. Malm. 2006. In vitro activity of caspofungin against planktonic and sessile Candida sp. cells. Pol. J. Microbiol. 55:133-137.
38. Shuford, J. A., M. S. Rouse, K. E. Piper, J. M. Steckelberg, and R. Patel. 2006. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J. Infect. Dis. 194:710-713.
39. Thein, Z. M., Y. H. Samaranayake, and L. P. Samaranayake. 2006. Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch. Oral Biol. 51:672-680.
40. Uppuluri, P., and W. L. Chaffin. 2007. Defining Candida albicans stationary phase by cellular and DNA replication, gene expression and regulation. Mol. Microbiol. 64:1572-1586.
41. Wenzel, R. P., and C. Gennings. 2005. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis. 41(Suppl. 6): S389-S393.
42. Zaoutis, T. E., J. Argon, J. Chu, J. A. Berlin, T. J. Walsh, and C. Feudtner. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41:1232-1239.